Outpace Bio raises $30m led by Artis Ventures, Lyell
The Seattle-based company raises funding from in an oversubscribed round led by Artis Ventures and Lyell Immunopharma.
1 April 2021•1 min read
The Seattle-based company raises funding from in an oversubscribed round led by Artis Ventures and Lyell Immunopharma.